XML 51 R28.htm IDEA: XBRL DOCUMENT v2.4.1.9
Segment Information
12 Months Ended
Dec. 31, 2014
Segment Reporting [Abstract]  
Segment Information
Segment Information
The Company operates in one segment, pharmaceuticals. Enterprise-wide disclosures about revenues, significant customers, and property and equipment, net by location are presented below.
Revenues by Product
Product revenues, net consisted of the following:
 
2014
 
2013
 
2012
 
(in thousands)
    KALYDECO
$
463,750

 
$
371,285

 
$
171,645

    INCIVEK
24,071

 
466,360

 
1,161,813

      Total product revenues, net
$
487,821

 
$
837,645

 
$
1,333,458


Revenues by Geographic Location
Total revenues from external customers and collaborators by geographic region consisted of the following. Product revenues are attributed to countries based on the location of the customer. Collaborative revenues are attributed to the operations of the Company in the United States. Royalty revenues are attributed to countries based on the location of the collaborator.
 
2014
 
2013
 
2012
 
(in thousands)
United States
$
361,074

 
$
896,952

 
$
1,373,516

Outside of the United States
 
 
 
 
 
Europe
197,611

 
279,557

 
129,786

Other
21,730

 
35,466

 
23,740

Total revenues outside of the United States
219,341

 
315,023

 
153,526

Total revenues
$
580,415

 
$
1,211,975

 
$
1,527,042


In 2014, revenues attributable to the United Kingdom were the majority of the Company’s European revenues.
Significant Customers
Gross revenues and accounts receivable from each of the Company’s customers who individually accounted for 10% or more of total gross revenues and/or 10% or more of total gross accounts receivable consisted of the following:
 
Percent of Total Gross Revenues
 
Percent of Gross Accounts Receivable
 
Year Ended December 31,
 
As of December 31,
 
2014
 
2013
 
2012
 
2014
 
2013
Walgreen Co.
12
%
 
<10
%
 
<10
%
 
11
%
 
<10
%
Bupa Home Healthcare Limited
<10
%
 
<10
%
 
N/A

 
20
%
 
14
%
Janssen Inc.
<10
%
 
N/A

 
N/A

 
12
%
 
N/A

Janssen NV
<10
%
 
22
%
 
<10
%
 
<10
%
 
28
%
AmerisourceBergen Drug Corporation
<10
%
 
21
%
 
32
%
 
<10
%
 
<10
%
McKesson Corporation
<10
%
 
21
%
 
29
%
 
<10
%
 
<10
%
Cardinal Health Incorporated
<10
%
 
<10
%
 
15
%
 
<10
%
 
<10
%

Property and Equipment, Net by Location
Property and equipment, net by location consisted of the following:
 
As of December 31,
 
2014
 
2013
 
(in thousands)
United States
$
676,968

 
$
657,587

Outside of the United States
 
 
 
United Kingdom
33,628

 
29,970

Other
5,216

 
9,354

Total property and equipment, net outside of the United States
38,844

 
39,324

      Total property and equipment, net
$
715,812

 
$
696,911